Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion

Aguilar, Maria I.; Hart, Robert G.; Kase, Carlos S.; Freeman, William D.; Hoeben, Barbara J.; García, Rosa C.; Ansell, Jack E.; Mayer, Stephan A.; Norrving, Bo; Rosand, Jonathan; Steiner, Thorsten; Wijdick, Eelco F. M.; Yamaguchi, Takenori; Yasaka, Masahiro
January 2007
Mayo Clinic Proceedings;Jan2007, Vol. 82 Issue 1, p82
Academic Journal
Wider use of oral anticoagulants has led to an increasing frequency of warfarin-related Intracerebral hemorrhage (ICH). The high early mortality of approximately 50% has remained stable in recent decades. In contrast to spontaneous ICH, the duration of bleeding Is 12 to 24 hours In many patients, offering a longer opportunity for intervention. Treatment varies widely, and optimal therapy has yet to be defined. An OVID search was conducted from January 1996 to January 2006, combining the terms warfarin or anticoagulation with Intracranial hemorrhage or Intracerebral hemorrhage. Seven experts on clinical stroke, neurologic Intensive care, and hematology were provided with the available information and were asked to independently address 3 clinical scenarios about acute reversal and resumption of anticoagulation in the setting of warfarin-associated ICH. No randomized trials assessing clinical outcomes were found on management of warfarin-associated ICH. All experts agreed that anticoagulation should be urgently reversed, but how to achieve it varied from use of prothrombin complex concentrates only (3 experts) to recombinant factor Vita only (2 experts) to recombinant factor Vita along with fresh frozen plasma (1 expert) and prothrombin complex concentrates or fresh frozen plasma (1 expert). All experts favored resumption of warfarin therapy within 3 to 10 days of ICH In stable patients in whom subsequent anticoagulation is mandatory. No general agreement occurred regarding subsequent anticoagulation of patients with atrial fibrillation who survived warfarin-associated ICH. For warfarin-associated ICH, discontinuing warfarin therapy with administration of vitamin K does not reverse the hemostatic defect for many hours and is inadequate. Reasonable management based on expert opinion includes a wide range of additional measures to reverse anticoagulation in the absence of solid evidence.


Related Articles

  • Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Wilson, S. Jo-Anne; Wells, Philip S.; Kovacs, Michael J.; Lewis, Geoffrey M.; Martin, Janet; Burton, Erica; Anderson, David R. // CMAJ: Canadian Medical Association Journal;8/19/2003, Vol. 169 Issue 4, p293 

    Background: There is growing evidence that better outcomes are achieved when anticoagulation is managed by anticoagulation clinics rather than by family physicians. We carried out a randomized controlled trial to evaluate these 2 models of anticoagulant care. Methods: We randomly allocated...

  • Corrections.  // American Family Physician;3/15/2006, Vol. 73 Issue 6, p974 

    Presents corrections to articles that were previously published in various issues, including "Warfarin Therapy: Evolving Strategies in Anticoagulation."

  • Warfarin/herbal medicines interaction.  // Reactions Weekly;11/13/2010, Issue 1327, p37 

    The article describes the case of a man who developed a cerebral haematoma while receiving concomitant therapy with warfarin and shengmaiyin, a Chinese combination herbal product.

  • Warfarin interaction.  // Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p261 

    This article presents a case study of a man in his 30s who diagnosed with intracerebral, intraventricular haemorrhages and cerebral venous thrombosis later developed subtherapeutic international normalized ratio (INR) levels after being treated with warfarin sodium and banana flakes supplement.

  • Rate of anticoagulant-associated intracerebral hemorrhage quintuples.  // Formulary;Apr2007, Vol. 42 Issue 4, p218 

    The article discusses the results of the study regarding the case of anticoagulant-associated intracerebral hemorrhage (ICH). According to an observational study published in the journal "Neurology," the rate of anticoagulant-associated ICH has increased since 1988. The case of ICH has been...

  • Confronting fears of anticoagulation therapy. Merli, Geno J. // Patient Care;Sep2002, Vol. 36 Issue 11, p8 

    Discusses how to confront fears of anticoagulation therapy. Factors influencing the safety and effectiveness of anticoagulation; Connection between physician's perceptions of the benefits and risks of warfarin influence on their decision to prescribe anticoagulants; Information on how to deal...

  • WARFARIN SODIUM DERIVATIVE: (COUMADIN® SODIUM). Shapiro, Shepard // Angiology;Aug1953, Vol. 4 Issue 4, p380 

    A new hypoprothrombinemia-inducing agent Coumarin® Sodium (warfarin sodium derivative) is described. It is soluble in water and can be administered intravenously. Its characteristics, dosage and the reasons for its advantages over the other 4-hydroxycoumarin anticoagulant drugs now in current...

  • Antibacterial prescribing and warfarin: a review. Rice, P J; Perry, R J; Afzal, Z; Stockley, I H // British Dental Journal;4/26/2003, Vol. 194 Issue 8, p411 

    Warfarin is the most commonly prescribed oral anticoagulant and is used in the management of thromboembolic disease. The practitioner is regularly faced with the need to prescribe concurrent antimicrobial therapy, either as prophylactic cover or in the therapeutic management of existing...

  • Patients can self-monitor warfarin.  // Pulse;1/15/2005, Vol. 65 Issue 2, p22 

    This article reports that patients who self-manage their anticoagulation treatment achieve a similar level of control as those who are managed by a doctor and suffer fewer adverse events. The percentage of patients who achieved target INRs was roughly the same in the two groups of patients, at...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics